| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 5763 | 2017 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update JS Smolen, RBM Landewé, JWJ Bijlsma, GR Burmester, M Dougados, ... Annals of the rheumatic diseases 79 (6), 685-699, 2020 | 2649 | 2020 |
| Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force JS Smolen, FC Breedveld, GR Burmester, V Bykerk, M Dougados, ... Annals of the rheumatic diseases 75 (1), 3-15, 2016 | 1660 | 2016 |
| Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score D Aletaha, VPK Nell, T Stamm, M Uffmann, S Pflugbeil, K Machold, ... Arthritis research & therapy 7, 1-11, 2005 | 1205 | 2005 |
| Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis VPK Nell, KP Machold, G Eberl, TA Stamm, M Uffmann, JS Smolen Rheumatology 43 (7), 906-914, 2004 | 1107 | 2004 |
| Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force JS Smolen, M Schöls, J Braun, M Dougados, O FitzGerald, DD Gladman, ... Annals of the rheumatic diseases 77 (1), 3-17, 2018 | 714 | 2018 |
| Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states D Aletaha, MM Ward, KP Machold, VPK Nell, T Stamm, JS Smolen Arthritis & Rheumatism 52 (9), 2625-2636, 2005 | 698 | 2005 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update JS Smolen, RBM Landewé, SA Bergstra, A Kerschbaumer, A Sepriano, ... Annals of the rheumatic diseases 82 (1), 3-18, 2023 | 569 | 2023 |
| Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis VPK Nell, KP Machold, TA Stamm, G Eberl, H Heinzl, M Uffmann, ... Annals of the rheumatic diseases 64 (12), 1731-1736, 2005 | 532 | 2005 |
| 2018 update of the EULAR recommendations for the management of hand osteoarthritis M Kloppenburg, FPB Kroon, FJ Blanco, M Doherty, KS Dziedzic, ... Annals of the rheumatic diseases 78 (1), 16-24, 2019 | 470 | 2019 |
| Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease KP Machold, TA Stamm, VPK Nell, S Pflugbeil, D Aletaha, G Steiner, ... Rheumatology 46 (2), 342-349, 2007 | 419 | 2007 |
| A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease … L Gossec, M de Wit, U Kiltz, J Braun, U Kalyoncu, R Scrivo, M Maccarone, ... Annals of the rheumatic diseases 73 (6), 1012-1019, 2014 | 386 | 2014 |
| Individual interviews and focus groups in patients with rheumatoid arthritis: A comparison of two qualitative methods M Coenen, TA Stamm, G Stucki, A Cieza Quality of life research 21, 359-370, 2012 | 371 | 2012 |
| Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease. KP Machold, TA Stamm, GJM Eberl, VKP Nell, A Dunky, M Uffmann, ... The Journal of rheumatology 29 (11), 2278-2287, 2002 | 320 | 2002 |
| Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update MA Stoffer, MM Schoels, JS Smolen, D Aletaha, FC Breedveld, ... Annals of the rheumatic diseases 75 (1), 16-22, 2016 | 309 | 2016 |
| EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2 RBM Landewé, PM Machado, F Kroon, HWJ Bijlsma, GR Burmester, ... Annals of the rheumatic diseases 79 (7), 851-858, 2020 | 296 | 2020 |
| Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis A Sepriano, A Kerschbaumer, JS Smolen, D Van Der Heijde, ... Annals of the rheumatic diseases 79 (6), 760-770, 2020 | 265 | 2020 |
| Joint protection and home hand exercises improve hand function in patients with hand osteoarthritis: a randomized controlled trial TA Stamm, KP Machold, JS Smolen, S Fischer, K Redlich, W Graninger, ... Arthritis Care & Research: Official Journal of the American College of …, 2002 | 240 | 2002 |
| 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis E Nikiphorou, EJF Santos, A Marques, P Böhm, JWJ Bijlsma, CI Daien, ... Annals of the rheumatic diseases 80 (10), 1278-1285, 2021 | 207 | 2021 |
| Validation of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis from the patient perspective using focus groups M Coenen, A Cieza, TA Stamm, E Amann, B Kollerits, G Stucki Arthritis research & therapy 8, 1-14, 2006 | 183 | 2006 |
Daniel AletahaProfessor of Rheumatology, Medical University Vienna在 meduniwien.ac.at 的电子邮件经过验证
